Biomerica Inc 's ability to collect accounts receivable sequentially worsen to 3.97, indicating more challenging environment then in the third quarter 2026, but still, it is a far cry from any concerns. Biomerica Inc 's Accounts Receivable average collection period in the May 31 2026 quarter, has increased to 92 days, from 76 days, in the Feb 28 2026 quarter.

If we take a look into Healthcare sector 182 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending May 31 2026 from 113 to 1407.

What is Receivable Turnover Ratio?
What is Biomerica Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BMRA Receivables Turnover Ratio	(May 31 2026) IV. Quarter	(Feb 28 2026) III. Quarter	(Nov 30 2025) II. Quarter	(Aug 31 2025) I. Quarter	(May 31 2025) IV. Quarter
Y / Y Receivable Change	119.97 %	-25.79 %	-22.81 %	-22.31 %	-22.81 %
Y / Y Revenue Change	16.96 %	-11.8 %	-26.04 %	-23.63 %	-33.01 %
Receivable Turnover Ratio (TTM)	3.97	4.8	4.53	4.71	4.72
BMRA's Total Ranking	# 1407	# 113	# 1387	# 315	# 1292
Accounts Receivable average collection period days	92	76	81	78	77
Seq. Receivable Change	70.88 %	28.73 %	-39.34 %	64.84 %	-42.35 %
Seq. Revenue Change	-11.25 %	-18.43 %	-12.32 %	84.25 %	-33.07 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 4
Healthcare Sector	# 183
Overall Market	# 1407

Receivable Turnover Ratio Statistics
High	Average	Low
1.41	0.84	0.43
(Aug 31 2022)		(Feb 29 2024)

BMRA Company Profile • Back to BMRA Efficiency Comparisons • Compare BMRA Receivables Turnover Ratio to its Competitors

Financial Statements
Biomerica Inc 's Accounts Receivable	$ 2 Millions	Visit BMRA's Balance sheet
Biomerica Inc 's Sales TTM	$ 4 Millions	Visit BMRA's Income Statement
Sources of BMRA's Revenues		Visit BMRA's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BMRA's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BMRA's Growth Rates	BMRA's Roa	BMRA's Inventory Turnover Ratio	BMRA's Dividend Comparisons
BMRA's Profitability Ratios	BMRA's Roi	BMRA's Asset Turnover Ratio	BMRA's Dividend Growth
BMRA's Valuation Ratios	BMRA's Roe	BMRA's Financial Strength Ratios	BMRA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending May 31 2026	Receivable at quarter ending May 31 2026
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Acadia Pharmaceuticals Inc	7.56	$ 1,138.643 Millions	$ 150.596 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Aurinia Pharmaceuticals Inc	7.55	$ 311.507 Millions	$ 41.274 Millions
Solventum Corporation	7.52	$ 8,310.000 Millions	$ 1,105.500 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions
Beta Bionics Inc	7.43	$ 119.513 Millions	$ 16.092 Millions
Seres Therapeutics Inc	7.42	$ 1.883 Millions	$ 0.254 Millions
Renovorx Inc	7.40	$ 1.976 Millions	$ 0.267 Millions
Maravai Lifesciences Holdings Inc	7.39	$ 207.886 Millions	$ 28.147 Millions
Koru Medical Systems Inc	7.38	$ 45.108 Millions	$ 6.114 Millions
Cerus Corporation	7.35	$ 221.224 Millions	$ 30.111 Millions
Lucid Diagnostics Inc	7.33	$ 5.445 Millions	$ 0.742 Millions
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions
Si bone inc	7.23	$ 214.331 Millions	$ 29.648 Millions
Safe Pro Group Inc	7.23	$ 2.881 Millions	$ 0.399 Millions
Insmed Inc	7.18	$ 1,076.572 Millions	$ 149.999 Millions
Rhythm Pharmaceuticals Inc	7.18	$ 239.918 Millions	$ 33.429 Millions
Twist Bioscience Corporation	7.10	$ 431.798 Millions	$ 60.812 Millions
Boston Scientific Corporation	7.10	$ 20,997.000 Millions	$ 2,957.500 Millions
Travere Therapeutics Inc	7.10	$ 591.330 Millions	$ 83.339 Millions
Angiodynamics Inc	7.08	$ 317.726 Millions	$ 44.853 Millions
Pulmonx Corporation	7.07	$ 87.393 Millions	$ 12.356 Millions
Arcturus Therapeutics Holdings Inc	7.05	$ 29.368 Millions	$ 4.168 Millions
Tandem Diabetes Care Inc	6.98	$ 1,037.302 Millions	$ 148.542 Millions

Date modified: 2026-09-05T08:34:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.